QVigilance

QVigilance is a specialist pharmacovigilance and risk management service provider serving biopharmaceutical companies, clinical trial sponsors, marketing authorisation holders, and medical device clients. The business was launched by Quanticate as a dedicated pharmacovigilance-focused offering and is positioned to support companies transitioning from clinical development to post-marketing operations. Its services include adverse event case processing and reporting, literature screening, aggregate safety reporting, signal detection and management, QPPV support, PSMF support, regulatory intelligence, and materiovigilance. QVigilance also offers hosted safety database capabilities and related compliance infrastructure for global safety operations. The company is service-based rather than a therapeutics developer, so it does not appear to maintain a proprietary drug pipeline.